Re: High rate of graft failure in 25 patients with chronic myelogenous leukemia conditioned with a reduced-intensity regimen of 550 cGy total body irradiation and cyclophosphamide for unrelated donor transplantation

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 10, 2004, Pages 726-727

  Hallemeier, C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMATINIB; METHOTREXATE; THYMOCYTE ANTIBODY;

ADULT; BONE MARROW CELL; CANCER MORTALITY; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CELL COUNT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; DISEASE ASSOCIATION; DONOR; DRUG EFFICACY; DRUG WITHDRAWAL; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LETTER; RADIATION DOSE; RISK REDUCTION; TREATMENT OUTCOME; VARIABLE NUMBER OF TANDEM REPEAT; WHOLE BODY RADIATION;

ADULT; CYCLOPHOSPHAMIDE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 4644336447     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.07.001     Document Type: Letter

References (9)

1. P.B. McGlave hu W. Wen et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program Blood 95 2000 2219-2225
2. J.A. Hansen T.A. Gooley P.J Martin et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia N Engl J Med 338 1998 962-968
3. H. Khoury D. Adkins R. Brown et al. Low incidence of transplant-related complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with low dose (550 cGy) total body irradiation conditioning regimen Biol Blood Marrow Transplant 7 2001 352-358
4. Girgis M. Hallemeier C. Blum W. et al. Chimerism and clinical outcomes of 110 unrelated donor bone marrow transplant recipients conditioned with low dose (550 cGy), single exposure total body irradation and cyclophosphamide. Blood. In press.
5. C. Hallemeier M. Girgis W Blum et al. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy single exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplantation Biol Blood Marrow Transplant 10 2004 310-319
6. M.B. Maris D. Niederwieser B.M Sandmaier et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies Blood 102 2003 2021-2030
7. M. Bornhäuser C. Thiede U Platzbecker et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients Clin Cancer Res 7 2001 2254-2262
8. D.J. De Angelo E.P. Hochberg E.P Alyea et al. Extended follow-up of patients treated with imatinib mesylate (Gleevec) for CML relapse following allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without GVHD Blood 102 2003 462b (abstr.)
9. E.C. Morris P. Rebello K.J Thomson et al. Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance of early adoptive immunotherapy and infectious complications Blood 102 2003 404-406